Effect of Total Alkaloids from Lotus Leaves on Body Mass and Lipid Regulation in Vivo and in Vitro .
范婷婷,法鲁克,方芳,蒋益虹
DOI: https://doi.org/10.3785/j.issn.1008‐9209.2012.11.064
2013-01-01
Abstract:Summary Obesity and disorder of lipid metabolism , also called dyslipidemia , have been one of the most important diseases threating people health worldwide , and is closely connected with hypertension , high serum glucose and other cardiac‐cerebral vascular diseases . The high fat diet is the main pathogenic cause of obesity and dyslipidemia , how to regulate blood lipid and control body mass effectively has been hotspots on nutriology research nowadays . Agents from natural products that inhibit fat digestion and absorption are of theoretical benefit in the treatment of obesity and dyslipidemia . Among them , lotus ( Nelumbo nuci f era) leaf is a kind of natural plant material used both in food and medicine , which contains multiple useful components . In modern research , scientists found that alkaloids were one of the main bioactive ingredients in them , helping lowing the serum lipid level and controlling body mass . Thus , this study aims to investigate the effect of lotus leaf total alkaloids on the body mass and lipid regulation in in vivo and in vitro experiments , and to find a new potential food additive to prevent effectively obesity from abnormal fat accumulation . Lipid‐lowering efficacy in vivo of lotus leaf total alkaloids was determined by animal experiment . After adapting to the feeding environment for 10 days , 30 experimental rats were randomly divided into six experimental groups according to their serum‐lipid level and body mass , including general diet group ( blank group) , high fat diet with lotus leaf total alkaloid ( high , moderate , low doses) groups , positive drug control group and high fat diet group ( model group) . Except for the general diet group feeding normal diet , the other five groups were fed high fat diet for 40 d to set up the model of hyperlipidemia rats . Then , the contents of TC ( total cholesterol) , TG ( triglyceride) , LDL‐C ( low density lipoprotein‐cholesterol) , HDL‐C ( high density lipoprotein‐cholesterol) , the levels of AST ( aspartate aminotransferase) and ALT ( alanine aminotransferase) in serum were assayed in hyperlipidemia rats which had been fed lotus leaf total alkaloids of 20 , 40 , 80 mg/( kg·d) and positive drug of 10 mg/( kg·d) simvastatin for another 40 days , respectively . In addition , the body mass and liver mass , body length , tail length were measured . Lipid‐lowering efficacy in vitro of lotus leaf total alkaloids was determined by measuring the inhibitory activity against pancrelipase by monitoring the hydrolysis of pNP‐b , which released the yellow chromogen p‐nitrophenol , and the buffer solution was adjusted to the condition of 37 ℃ , pH=7 .4 . The results showed that , compared with high fat diet group ( model group ) , the body mass decreased significantly in the high fat diet with lotus leaf total alkaloid ( high , moderate , low doses) groups , as well as the Lee s index , liver and spleen mass of rats;moreover , the contents of TC , TG , LDL‐C , the levels of AST and ALT in serum and atherosclerosis index ( AI) were significantly decreased and the ratios of HDL‐C/TC and apoAI/apoB increased in the hyperlipidemia rat fed with lotus leaf total alkaloids . The maximum inhibitory rate of lotus leaf total alkaloids of 600 μg/mL against pancrelipase activity was 25 .6% . Based on the Linweaver‐Burk plots , the lipase inhibitor demonstrated non‐competitive inhibition for pancrelipase . It is concluded that the lotus leaf total alkaloids are effective in significant reduction of body mass , body fat and obesity‐related body indicators , and can inhibit lipase activity . Also , it is sure that the alkaloids from lotus leaves have potential to prevent effectively obesity from abnormal fat accumulation .